Saturday, May 23, 2026
ADVT 
Health

Brain Scans Reveal Hidden Consciousness In Patients

The Canadian Press, 26 May, 2016 11:45 AM
    NEW YORK — A standard brain scanning technique is showing promise for helping doctors distinguish between patients in a vegetative state and those with hidden signs of consciousness.
     
    A study released Thursday is the latest to investigate using technology to help meet the challenge of making that distinction, which now is generally based on a doctor's bedside exam.
     
    Patients in a vegetative state have open eyes and show periods of sleep and wakefulness, but they are unaware of themselves or others and unable to think, respond or do anything on purpose. Patients in a minimally conscious state show only intermittent and minimal signs of awareness of themselves or their environment.
     
    Distinguishing between those two conditions is important because patients with even minimal awareness can be treated to help them communicate and to prevent suffering. They respond much better to stimulation from medication or sounds, touch, music and odours.
     
     
    In the new research, released by the journal Current Biology, researchers from Denmark, Belgium and Yale University investigated using so-called FDG-PET scans to measure the brain's consumption of blood sugar, which brain cells use as fuel. They sought to establish a specific level of consumption that could distinguish between the two groups of patients.
     
    They studied 49 vegetative patients and 65 minimally conscious ones, diagnosed by standard bedside procedures. They found that using a particular cutoff for PET scan results, they could correctly identify patient status 88 per cent of the time.
     
    The researchers checked the patient status again a year later. They found that 8 of the 11 vegetative patients who had scored above the cutoff, which had been associated with minimal consciousness, had in fact recovered consciousness. The other three had died.
     
    Three minimally conscious patients had scored below the cutoff. Of the two patients the researchers could find a record for, one showed no change and the other had died.
     
    Dr. Nicholas Schiff, a professor of neurology and neuroscience at the Weill Cornell Medical College in New York, who didn't participate in the work, called the work "very important." Such tests could encourage early diagnosis and promote proper care, he said.

    MORE Health ARTICLES

    Probiotics help reduce fat in liver

    Probiotics help reduce fat in liver
    For people suffering from non-alcoholic fatty liver disease, eating probiotics for a month can help diminish the accumulation of fat in the liver...

    Probiotics help reduce fat in liver

    Now, cancer vaccine from cat poop parasite

    Now, cancer vaccine from cat poop parasite
    You may soon look at cat poop in a different light as it may hold the key to cancer cure.

    Now, cancer vaccine from cat poop parasite

    Gene that mediates ageing identified

    Gene that mediates ageing identified
    In what could point towards the possibility of one day using therapeutics to combat ageing, researchers have found in animal models that a single gene plays a surprising role in ageing that can be detected early in development.

    Gene that mediates ageing identified

    Starvation effects pass on to next 3 generations

    Starvation effects pass on to next 3 generations
    Starvation may affect the health of at least the next three generations, says a study.

    Starvation effects pass on to next 3 generations

    Busiest hospital best for emergency patients

    Busiest hospital best for emergency patients
    When a medical emergency strikes, instinct tells us to go to the nearest hospital quickly.

    Busiest hospital best for emergency patients

    Common cholesterol drug linked to death risk

    Common cholesterol drug linked to death risk
    Niacin, a common cholesterol drug for 50 years, should no longer be prescribed owing to potential increased risk of death, dangerous side effects and no benefit in reducing heart attacks and strokes, researchers said.

    Common cholesterol drug linked to death risk